Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
It is the world’s first DNA-based Covid vaccine
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Expertise in exosomes isolation and characterization will drive innovation in this field
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Subscribe To Our Newsletter & Stay Updated
